Study has been shown that blockade of CSF2 signaling reduces airway inflammation and hyperresponsiveness in mouse models of environmentally induced lung injury and asthma (Burkhardt et al., 2012; Gilchrist et al., 2021). The gene discussed is CSF2; the disease is asthma.